Analisis Faktor Risiko Pasien Penyakit Ginjal Kronik yang Menjalani Hemodialisis

  • Mohamad Nur Politeknik Negeri Madura
  • Nur Khalilah Politeknik Negeri Madura
  • Anggeria Oktavisa Denta Politeknik Negeri Madura
  • Elyk Dwi Mumpuningtias Universitas Wiraraja
Keywords: Chronic Kidney Disease, Dietary, Hemodialysis, Hypertension.

Abstract

Chronic Kidney Disease (CKD) is a global health problem with increasing number of cases and morbidity rates. This study aims to analyze the risk factors associated with CKD in patients receiving hemodialysis therapy. The study design used a case-control study approach with 30 respondents selected purposively, consisting of 15 CKD patients as the case group and 15 hypertensive patients without CKD as controls. Inclusion criteria for the case group included patients aged 30–65 years who had been diagnosed with end-stage CKD and underwent regular hemodialysis, while the control group consisted of hypertensive patients without impaired kidney function with the same age. All respondents must be willing to participate in the study and sign an informed consent. The exclusion criteria for both groups included patients with a history of autoimmune disease, diabetes mellitus, other chronic diseases that affect kidney function, long-term use of nephrotoxic drugs, and the inability to fully participate in the research process. The research data were analyzed using the chi-square test to determine the relationship between hypertension, diet, and the risk of CKD. Statistical tests showed that a history of hypertension increased the risk of CKD with a p value of 0.003, unhealthy diet was associated with CKD with a p value of <0.05, and the relationship between hypertension and CKD risk with a ϕ value of 0.533. The results of this study indicate that hypertension and unhealthy diet play a significant role in the development of CKD, providing important guidance for health intervention programs. Hypertension and unhealthy diet are major risk factors for CKD in hemodialysis patients.

References

Akhtar, Z. et al. (2022) ‘Cardiovascular Disease in Chronic Kidney Disease Arrhythmias in Chronic Kidney Disease Mechanisms of Arrhythmia in Renal Failure Arrhythmias in Chronic Kidney Disease’.
Bikbov, B. et al. (2020) ‘Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017’, The Lancet, 395(10225), pp. 709–733. doi: 10.1016/S0140-6736(20)30045-3.
Carney, E. F. (2020) ‘The impact of chronic kidney disease on global health’, Nature Reviews Nephrology. Springer US, 16(5), p. 251. doi: 10.1038/s41581-020-0268-7.
Cuenca, D. (2023) ‘Journal of Population Therapeutics & Clinical Pharmacology’, 30(June), pp. 434–445. doi: 10.47750/jptcp.2023.30.15.050.
Goldberg, I. and Krause, I. (2016) ‘The Role of Gender in Chronic Kidney Disease’, European Medical Journal, (April), pp. 58–64. doi: 10.33590/emj/10312319.
He, F. J., Li, J. and MacGregor, G. A. (2013) ‘Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials’, BMJ (Online), 346(7903), pp. 1–15. doi: 10.1136/bmj.f1325.
Jha, V. et al. (2013) ‘Chronic kidney disease: Global dimension and perspectives’, The Lancet. Elsevier Ltd, 382(9888), pp. 260–272. doi: 10.1016/S0140-6736(13)60687-X.
Kearney, P. M. et al. (2005) ‘Global burden of hypertension: analysis of worldwide data’, The Lancet, 365(9455), pp. 217–223. doi: 10.1016/s0140-6736(05)17741-1.
Kemenkes (2018) ‘Laporan Riskesdas 2018 Nasional.pdf’. Jakarta: Badan Penelitian dan Pengembangan Kesehatan.
Levey, A. S. and Coresh, J. (2012) ‘Chronic kidney disease’, The Lancet. Elsevier Ltd, 379(9811), pp. 165–180. doi: 10.1016/S0140-6736(11)60178-5.
Ortiz, A. et al. (2014) ‘Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure.’, Lancet (London, England). England, 383(9931), pp. 1831–1843. doi: 10.1016/S0140-6736(14)60384-6.
Pecoits-Filho, R. et al. (2020) ‘Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes’, Kidney International Supplements. Elsevier Inc, 10(1), pp. e3–e9. doi: 10.1016/j.kisu.2019.11.001.
Pugh, D., Gallacher, P. J. and Dhaun, N. (2020) ‘Management of Hypertension in Chronic Kidney Disease’, Drugs. Springer International Publishing, 79(4), pp. 365–379. doi: 10.1007/s40265-019-1064-1.
Rysz, J. et al. (2017) ‘Novel biomarkers in the diagnosis of chronic kidney disease and the prediction of its outcome’, International Journal of Molecular Sciences, 18(8). doi: 10.3390/ijms18081702.
Stanifer, J. W. et al. (2016) ‘Chronic kidney disease in low- and middle-income countries’, Nephrology Dialysis Transplantation, 31(6), pp. 868–874. doi: 10.1093/ndt/gfv466.
Stenvinkel, P. et al. (2021) ‘Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2’, Kidney International Reports. Elsevier Inc, 6(7), pp. 1775–1787. doi: 10.1016/j.ekir.2021.04.023.
Published
2025-05-31
Abstract viewed = 107 times
PDF downloaded = 119 times